文献速递瓣膜外科

主动脉瓣置换术后新发房颤对长期生存的影响

New-onset postoperative atrial fibrillation after aortic valve replacement: Effect on long-term survival.
PubMed 文献 · J Thorac Cardiovasc Surg · 2017-03-12

该回顾性纵向队列研究纳入1990至1994年间569例无房颤史的主动脉瓣置换术患者,其中241例(42.4%)出现术后新发房颤。平均随访17.8±1.9年,新发房颤组与无房颤组15年累积生存率相似(41.5% vs 41.3%),新发房颤并非长期生存下降的独立危险因素(HR 0.815;95%CI 0.663-1.001;

要点

  • 主动脉瓣置换术后新发房颤发生率为42.4%。
  • 平均随访17.8年,新发房颤未显著影响长期生存。
  • 出院前以恢复窦性心律为目标治疗新发房颤。

核心结论

  • 主动脉瓣置换术后新发房颤在出院前以恢复窦性心律为治疗目标时,不影响长期生存。

研究设计与样本

  • 回顾性纵向队列研究,纳入1990年1月1日至1994年1月1日期间连续569例无房颤史的行主动脉瓣置换术患者。
  • 按术后是否新发房颤分为241例(42.4%)新发房颤组和328例(57.6%)无新发房颤组,平均随访17.8±1.9年。

主要发现

  • 新发房颤组与无新发房颤组15年随访时Kaplan-Meier总体累积生存率相似:41.5%(95%CI 35.2-47.7) vs 41.3%(95%CI 36.0-46.7)。

关键数值与推荐

  • 术后新发房颤患者以在发病后24至48小时内通过药物恢复窦性心律为目标,药物失败时在出院前行直流电复律。

临床怎么用

  • 主动脉瓣置换术后新发房颤患者应积极尝试在出院前恢复窦性心律,此举可能抵消其对长期生存的不利影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: There is a paucity of data on long-term survival of new-onset postoperative atrial fibrillation (POAF) after cardiac surgery. Also, mean follow-up in previous studies is confined to a maximum of one decade. This retrospective, longitudinal cohort study was performed to determine the effect on long-term survival of new-onset POAF after aortic valve replacement (AVR) over a mean follow-up of almost 2 decades. METHODS: Kaplan-Meier survival analysis was used to determine long-term survival after AVR, performed between January 1, 1990, and January 1, 1994, in 569 consecutive patients without a history of atrial fibrillation, divided into 241 patients (42.4%) with and 328 patients (57.6%) without new-onset POAF. New-onset POAF was considered in multivariable analysis for decreased long-term survival. After AVR, patients with new-onset POAF were treated with the aim to restore sinus rhythm within 24 to 48 hours from onset by medication and when medication failed by direct-current cardioversion before discharge home. RESULTS: Mean follow-up after AVR was 17.8 ± 1.9 years. Incidence of new-onset POAF was 42.4%. Kaplan-Meier overall cumulative survival rates at 15 years of follow-up were similar in the patients with new-onset POAF versus those without: 41.5% (95% confidence interval [CI], 35.2-47.7) versus 41.3% (95% CI, 36.0-46.7), respectively. New-onset POAF was not an independent risk factor for decreased long-term survival (hazard ratio 0.815; 95% CI, 0.663-1.001; P = .052). CONCLUSIONS: New-onset POAF after AVR does not affect long-term survival when treatment is aimed to restore sinus rhythm before discharge home.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Swinkels BM, de Mol BA, Kelder JC, et al. New-onset postoperative atrial fibrillation after aortic valve replacement: Effect on long-term survival. J Thorac Cardiovasc Surg. 2017. PMID: 28390762. doi:10.1016/j.jtcvs.2017.02.052

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。